ArticleiScience2024

Genome-scale CRISPR-Cas9 screen identifies host factors as potential therapeutic targets for SARS-CoV-2 infection.

Madoka Sakai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.